1. Scrip
  2. >>COVID-19

Coronavirus Update: Takeda Contractor To Manufacture J&J Vaccine; Moderna Starts Pediatric Trial

Also, GSK Begins Vaccine Trial With Partner Medicago

 
• By Scrip Team

Takeda agreed with its contract manufacturer to grant access to its dengue vaccine production capacity for Johnson & Johnson's COVID-19 vaccine. Frontrunner Moderna started a pediatric trial in children as young as six months. GSK and Medicago began the Phase III portion of a Phase II/III vaccine trial. And China is limiting inbound travel to people vaccinated with China-made vaccines.

Coronavirus
Vaccines in the spotlight as new trials begin, manufacturing ramps up • Source: Shutterstock

Takeda Pharmaceutical Co. Ltd. has entered into an agreement with the German contract development and manufacturing organization IDT Biologika GmbH to temporarily utilize capacity at IDT previously reserved for Takeda’s dengue vaccine candidate, TAK-003, for the manufacture of Janssen Pharmaceutical Cos.’s one-shot COVID-19 vaccine JNJ-78436735.

At the end of a three-month period, the capacity will be returned to Takeda to resume manufacturing for the planned launch of its dengue vaccine, for which the Japanese firm currently anticipates the first approvals sometime in fiscal 2021 (beginning this 1 April)

More from COVID-19

More from Scrip

Merck KGaA Braces For Volatility But Does Not Expect Europe To Budge On Pricing

 
• By Andrew McConaghie

Shares are hit as German conglomerate lowers revenue forecast.

Leo Roars To A Profit In Q1 As Adbry Grows In US

 
• By Kevin Grogan

The Danish firm's atopic dermatitis drug is holding its own despite strong competition from Sanofi/Regeneron’s Dupixent.

Cipla Leadership’s Early Take On Trump’s Pricing EO And Pipeline Progress

 
• By Anju Ghangurde

Cipla's CEO underlines that US generic prices are already “very significantly comparable” with the rest of the world and expects President Donald Trump's executive order on drug pricing to primarily impact branded pharmaceuticals. The company also shared updates on its US pipeline.